ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Mexico » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in New Mexico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT GALAGAN MD

Endocrinology, Diabetes Metabolism

5,778

$673K

476
379 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 44%

$116
Average prescription price

Avg: $117

ROBERT FERRARO MD

Endocrinology, Diabetes Metabolism

5,310

$647K

437
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 44%

$122
Average prescription price

Avg: $117

IVAN PINON MD

Endocrinology, Diabetes Metabolism

4,495

$528K

449
330 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 44%

$118
Average prescription price

Avg: $117

NEIL KAMINSKY MD

Endocrinology, Diabetes Metabolism

4,240

$459K

352
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 44%

$108
Average prescription price

Avg: $117

JEREMY GLEESON MD

Endocrinology, Diabetes Metabolism

3,825

$504K

464
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 44%

$132
Average prescription price

Avg: $117

MAY REYES MD

Endocrinology, Diabetes Metabolism

3,613

$398K

403
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 44%

$110
Average prescription price

Avg: $117

HEMANTH PAI MD

Endocrinology, Diabetes Metabolism

3,208

$384K

338
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 44%

$120
Average prescription price

Avg: $117

ALISON SAWYER MD

Endocrinology, Diabetes Metabolism

3,050

$465K

313
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 44%

$153
Average prescription price

Avg: $117

JOHN SEIBEL MD

Endocrinology, Diabetes Metabolism

2,987

$374K

262
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 44%

$125
Average prescription price

Avg: $117

DAVID PODOLSKY MD

Endocrinology, Diabetes Metabolism

2,866

$387K

378
267 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 44%

$135
Average prescription price

Avg: $117

ANDREW LANCASTER MD

Endocrinology, Diabetes Metabolism

2,665

$297K

239
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 44%

$111
Average prescription price

Avg: $117

TERRY EDWARDS MD

Endocrinology, Diabetes Metabolism

2,377

$269K

245
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 44%

$113
Average prescription price

Avg: $117

ELIZABETH BATCHER MD

Endocrinology, Diabetes Metabolism

2,119

$231K

318
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 44%

$109
Average prescription price

Avg: $117

MARTA TERLECKI MD

Endocrinology, Diabetes Metabolism

2,013

$113K

283
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

62%
prescriptions for brand name drugs

Avg: 44%

$56
Average prescription price

Avg: $117

MARGARET LONGLEY CNP

Endocrinology, Diabetes Metabolism

1,791

$179K

295
244 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 44%

$100
Average prescription price

Avg: $117

PATRICIA KAPSNER MD

Endocrinology, Diabetes Metabolism

1,403

$185K

98
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 44%

$132
Average prescription price

Avg: $117

JOHN REYNOLDS MD

Endocrinology, Diabetes Metabolism

1,279

$130K

179
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

71%
prescriptions for brand name drugs

Avg: 44%

$102
Average prescription price

Avg: $117

GREGORY JOHNSON M.D.

Endocrinology, Diabetes Metabolism

1,130

$117K

100
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 44%

$103
Average prescription price

Avg: $117

APARIMITA LAHIRI MBBS/M.D.

Endocrinology, Diabetes Metabolism

1,086

$103K

88
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 44%

$95
Average prescription price

Avg: $117

RACHAEL CUNNICK PA-C

Endocrinology, Diabetes Metabolism

969

$174K

195
127 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 44%

$180
Average prescription price

Avg: $117

ROBERT BERNSTEIN MD

Endocrinology, Diabetes Metabolism

954

$103K

108
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 44%

$108
Average prescription price

Avg: $117

MADHAVI GARIMELLA M.D.

Endocrinology, Diabetes Metabolism

879

$62.7K

103
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 44%

$71
Average prescription price

Avg: $117

MATTHEW BOUCHONVILLE, II MD

Endocrinology, Diabetes Metabolism

593

$83.8K

99
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 44%

$141
Average prescription price

Avg: $117

MARK BURGE MD

Endocrinology, Diabetes Metabolism

315

$30.2K

33
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 44%

$96
Average prescription price

Avg: $117

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank